share_log

Visa | N-PX: Others

Visa | N-PX: Others

Visa | N-PX：其他
美股SEC公告 ·  08/09 16:08
Moomoo AI 已提取核心訊息
The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form S-3 for iBio, Inc. The notice, issued from Washington, D.C., indicates that the form became effective on August 6, 2024, at 4:00 P.M. This form is typically used by companies to register securities for potential future offerings. The SEC's notice confirms that iBio, Inc., which is listed under the Central Index Key (CIK) number 0001420720 and has the file number 333-280680, has met the requirements for this registration statement to become effective.
The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form S-3 for iBio, Inc. The notice, issued from Washington, D.C., indicates that the form became effective on August 6, 2024, at 4:00 P.M. This form is typically used by companies to register securities for potential future offerings. The SEC's notice confirms that iBio, Inc., which is listed under the Central Index Key (CIK) number 0001420720 and has the file number 333-280680, has met the requirements for this registration statement to become effective.
美國證券交易委員會（SEC）已宣佈iBio公司Form S-3表格的效力。這個通知是從華盛頓特區發出的，表明該表格於2024年8月6日下午4:00生效。此表通常用於公司註冊證券以備未來可能的發行。SEC的通知確認了iBio公司已滿足這個註冊聲明的要求，並列在中央指數密鑰（CIK）號碼0001420720下，擁有文件編號333-280680。
美國證券交易委員會（SEC）已宣佈iBio公司Form S-3表格的效力。這個通知是從華盛頓特區發出的，表明該表格於2024年8月6日下午4:00生效。此表通常用於公司註冊證券以備未來可能的發行。SEC的通知確認了iBio公司已滿足這個註冊聲明的要求，並列在中央指數密鑰（CIK）號碼0001420720下，擁有文件編號333-280680。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息